Charles River Laboratories International, Inc. (CRL) Stock Up After Upgrade at Evercore ISI

Charles River Laboratories International, Inc. (NYSE: CRL) shares rose in value Wednesday Jan 4 with slower trade volume than normal after a number of analysts weighed in on the investing value of the stock with a upgraded rating.

Meanwhile, U.S. stocks opened higher on Wednesday as banking stocks led the Dow Jones Industrial Average closer to the 20,000 milestone.

The Dow DJIA, +0.18% gained 25 points, or 0.1%, to 19,906. The S&P 500 SPX, +0.36% climbed four points, or 0.2%, to 2,262. The Nasdaq Composite Index COMP, +0.50% added 13 points, or 0.3%, to 5,447.

Analysts at Evercore ISI upgraded shares of Charles River Laboratories International, Inc. (NYSE: CRL) from Hold to Buy today. The company currently has a rating of Buy on the shares. The one-year price target of $85.43 is higher than the opening price of $77.34, causing a fair amount of other analysts to issue statements on the company recently. Looking back over the last 52 weeks, Charles River Laboratories International, Inc. stock has a high of $89.18. Usually, after analysts publish an upgrade report on a stock, they will later issue periodic updates, usually followed by a price target change.

Shares of Charles River Laboratories International, Inc. (NYSE: CRL) opened at $77.34 on Tuesday and has traded in a range between, $77.31 and $78.57, and last traded at $78.33, which represents an increase of $1.80 or 0.02 over the previous closing price.

Charles River Laboratories International, Inc. (NYSE: CRL) now has a market cap of 3.71B.

Charles River Laboratories International, Inc. (NYSE: CRL) Average Daily Trading Volume

99,619 shares crossed the trading desk yesterday, below normal, out of a total float 46,542,000. lower than normal. Look for trading volume to pick up in the coming days as investors often use upticks in trading volume to identify heavy volume accumulation or distribution by institutional investors.

As with all potential breakouts, investors look for volume to be at least 40%-50% higher than normal on the breakout to show that fund managers and other professional investors are jumping in.

Institutional sponsorship just refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Professional investors such as these have teams of analysts that investigate thousands of stocks, so it is good corroboration to see them taking a postion in a stock you’re considering.

Charles River Laboratories International, Inc. (NYSE: CRL) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By spotting trends, moving averages allow investors to make those trends work in their favor and increase the number of winning trades.

With that in mind, Charles River Laboratories International, Inc. (NYSE: CRL) now has a 50-day MA of $73.93 and 200-day MA of $79.98. It has traded in a 52-week range between $65.70 – 89.1800 and today’s last price is 0.12% lower than the 52 week high of $89.18.

Indeed, earnings growth is among the most critical things to look at in regards to stock investing and, accordingly, investors watch for companies that have increased their earnings by at least 25% for 3 consecutive years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *